{"@type":"Dataset","go_id":["https://identifiers.org/GO:0006629","https://identifiers.org/GO:0006954","https://identifiers.org/GO:0006955"],"go_kw":["lipid metabolism","inflammation","immune response"],"integmet_study":"MTBLS33","mesh_chemical_id":["https://identifiers.org/mesh:D008055"],"mesh_chemical_pubtator_kw":["lipid"],"mesh_disease_id":["https://identifiers.org/mesh:D007239","https://identifiers.org/mesh:D007249","https://identifiers.org/mesh:D007251"],"mesh_disease_pubtator_kw":["infection","inflammation","influenza infection","influenza","Infection","inflammatory"],"mesh_gene_id":["https://identifiers.org/ncbigene:11689"],"mesh_gene_pubtator_kw":["5-lipoxygenase"],"ncbi_taxonomy_id":["https://identifiers.org/taxonomy:9606","https://identifiers.org/taxonomy:114727","https://identifiers.org/taxonomy:119210"],"ncbi_taxonomy_pubtator_kw":["human","H1N1","H3N2"],"source_id":"https://identifiers.org/metabolights:MTBLS33","study_findings":"5-lipoxygenase metabolites correlate with pathogenic phase; 12/15-lipoxygenase with resolution phase.","study_observation":"Lipid mediators in BALF post-influenza infection in mice.","study_summary":"Lipid mediators in influenza-induced inflammation.","study_title_original":"Lipid mediators of inflammation in BALF 3-11 days after infection with influenza."}